Clinical Evidence: How Weight Loss Results Compare
Weight Loss on Wegovy vs Mounjaro: Understanding the Key Differences
Weight loss on Wegovy utilises semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and increase satiety. In contrast, Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors, potentially offering a dual-pathway approach to weight management. The fundamental difference lies in their mechanisms: whilst weight loss on Wegovy focuses on the established GLP-1 pathway proven in extensive clinical trials, Mounjaro's dual-hormone approach represents a newer treatment strategy. Both medications require weekly injections and must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
When considering weight loss on Wegovy versus Mounjaro, practical factors often influence the decision as much as clinical mechanisms do. Wegovy follows a five-dose escalation schedule from 0.25mg to 2.4mg maintenance, whilst Mounjaro offers six doses ranging from 2.5mg to 15mg maximum. Storage requirements favour Wegovy, which maintains stability for six weeks at room temperature compared to Mounjaro's 21-day limit—a crucial consideration for frequent travellers or those with limited refrigerator access. Both treatments are available through EverydayMeds with identical clinical assessment processes, ensuring your prescriber can evaluate which option aligns best with your medical history and lifestyle needs.
Wegovy and Mounjaro Pricing: Complete Cost Breakdown
Understanding the true cost of weight loss on Wegovy versus Mounjaro requires examining both single pen prices and bundle options across the dose escalation journey. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles offer convenience for the escalation phase: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) provides three months of step-up dosing for £369.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro pricing reflects its higher-strength formulation, with costs typically exceeding Wegovy at equivalent treatment stages, though individual insurance coverage and patient response may influence the overall value proposition. For patients reaching maintenance dosing, our Consistency bundles provide ongoing supply security: Consistency 2.4mg (×2) offers eight weeks of Wegovy maintenance for £419.99, whilst the Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. Both treatments require identical clinical oversight and cold-chain delivery, ensuring medication integrity regardless of your chosen option. EverydayMeds' transparent pricing model includes no hidden consultation fees, prescription charges, or delivery costs beyond the stated pen prices.
Clinical Evidence: STEP Trials and Weight Loss on Wegovy
Weight loss on Wegovy demonstrates robust clinical evidence through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, as reported by Wilding et al. in the New England Journal of Medicine, 2021. STEP 3 demonstrated even greater results of approximately clinically studied weight loss when Wegovy was combined with intensive behavioural therapy, whilst STEP 5 confirmed sustainability with clinically studied weight loss maintained at two years. These results consistently showed that patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved clinically meaningful weight reduction compared to lifestyle interventions alone.
The SELECT trial further established cardiovascular benefits of weight loss on Wegovy, demonstrating a 20% reduction in major cardiovascular events (hazard ratio 0.80) in adults with established cardiovascular disease and overweight or obesity. NICE guidelines (TA875) recommend Wegovy with specialist weight management support, recognising both its efficacy and the importance of comprehensive care. Mounjaro's SURMOUNT trials show comparable efficacy through different mechanisms, though direct head-to-head comparisons remain limited due to different trial designs and patient populations.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Weight loss on Wegovy occurs through semaglutide's action as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood sugar and appetite after meals. When you inject Wegovy weekly, it activates GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, reducing hunger signals and increasing feelings of fullness or satiety. This mechanism also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satisfaction after smaller meals and reduced between-meal snacking. The medication works synergistically with lifestyle modifications, making it easier to adhere to a reduced-calorie diet by naturally diminishing food cravings and portion sizes. Unlike appetite suppressants that directly block hunger signals, Wegovy works with your body's existing regulatory systems to restore more normal appetite control and eating patterns.
Ordering Process: From Assessment to Delivery
Accessing weight loss on Wegovy through EverydayMeds begins with our comprehensive three-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any contraindications. Our qualified prescribers review your assessment within standard three working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your individual circumstances and BMI requirements. Once approved, your prescription is fulfilled by our GPhC-registered pharmacy (#9012878) with next-day delivery via temperature-controlled cold-chain logistics to maintain medication integrity. Each Wegovy FlexTouch pen arrives with detailed administration instructions, dose escalation schedule, and direct access to our clinical support team for any questions during treatment. The same streamlined process applies whether you're starting with single pens or choosing our convenient bundle options for multi-month supply security.
Storage and Practical Considerations for Wegovy Treatment
Proper storage ensures optimal effectiveness of weight loss on Wegovy throughout your treatment journey, with unused pens requiring refrigeration at 2-8°C until first use. Once removed from the refrigerator, Wegovy maintains stability for up to six weeks at room temperature below 30°C, offering significant practical advantages over Mounjaro's 21-day room temperature limit for travel, work schedules, or temporary refrigeration unavailability. The FlexTouch pen design provides precise dosing with an easy-to-use mechanism suitable for weekly self-injection, typically in the thigh, upper arm, or abdomen. Dose escalation follows a mandatory schedule—starting at 0.25mg for four weeks, then 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance—with each increase allowing your body to adjust and minimising potential side effects. Never skip doses or accelerate the escalation timeline, as this predetermined schedule optimises both tolerability and effectiveness throughout your weight loss journey.
Personalised Treatment Selection: Matching Your Lifestyle Needs
Choosing between weight loss on Wegovy versus Mounjaro often depends on individual factors beyond clinical efficacy, including injection frequency preferences, storage requirements, and previous treatment responses. Wegovy's longer room temperature stability makes it ideal for frequent travellers, shift workers, or anyone with limited reliable refrigeration access, whilst its well-established clinical profile provides confidence for both patients and prescribers. Some patients may respond better to Wegovy's single-pathway GLP-1 approach, whilst others might benefit from Mounjaro's dual-hormone mechanism, making individualised prescriber assessment crucial for optimal outcomes.
EverydayMeds' unique position of stocking both treatments allows your prescriber to recommend the most appropriate option without commercial bias or stock limitations affecting clinical decisions. Our clinical team can guide switches between treatments if initial response is suboptimal, ensuring continuity of care throughout your weight management journey. Both medications require identical lifestyle commitments and clinical monitoring, meaning your choice can focus purely on medical suitability and practical preferences rather than treatment complexity differences.
Start Your Weight Loss Journey: Choose Wegovy or Mounjaro Today
Weight loss on Wegovy represents a clinically proven approach to sustainable weight management, available through EverydayMeds with complete pricing transparency and expert clinical support from our GPhC-registered pharmacy (#9012878). New customers use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing starting from £79.99 for initial doses. Our comprehensive online assessment takes just three minutes to complete, with qualified prescribers reviewing your suitability for either Wegovy or Mounjaro based on your individual medical profile and treatment goals. Both treatments arrive via next-day temperature-controlled delivery, ensuring medication integrity and treatment effectiveness from the moment you begin. Visit https://everydaymeds.co.uk/collections/weight-loss to start your clinical assessment today and discover which prescription-only weight management treatment aligns best with your needs and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
